Why the study?
How does patient performance status influence expert physician decisions to prescribe thromboprophylaxis in palliative care?
How does patient performance status influence expert physician decisions to prescribe thromboprophylaxis in palliative care?
Expert physicians tailor thromboprophylaxis in palliative care patients based on a compound estimate of risks and benefits, heavily influenced by the patient's performance status.
Answers are grounded in this paper and cite their sources.
Physicians commonly withhold VTE prophylaxis at low performance status in palliative care; this observational finding leaves open the impact on outcomes.
Study-based guidelines on thromboprophylaxis are not available for palliative care patients. The authors asked a panel of academic medical experts in palliative care, oncology, blood coagulation, and intensive care to select a prophylactic regimen out of 5 predefined options for a virtual patient with advanced bronchial cancer in different clinical settings. Primary prophylaxis for venous thromboembolism was withdrawn by all physicians when the patient had a Karnovsky's index of 10 and was described as dying. It was given by 25% of physicians when the patient had a Karnovsky's index of 20 and by 85% when Karnovsky's index 40 was still 40. Similar results were obtained in the situation of secondary prophylaxis of venous thromboembolism and when the patient was described as having a history of chronic atrial fibrillation. This data clearly show that thromboprophylaxis is delivered according to a compound estimate of risks and benefits of such prophylaxis in a specific palliative care situation.
No takes yet. Share an insight, caveat, or question.
Kierner et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: